Drug intelligence / Profile preview

low molecular weight heparin calcium (Henan University of Chinese Medicine)

Development stage
Unknown
Lead developer
Henan University of Chinese Medicine
Modality
Small Molecules
Administration
Subcutaneous
01

Overview

Low molecular weight heparin calcium is an anticoagulant small molecule drug derived from heparin. It functions primarily by binding to and enhancing the activity of antithrombin III, which in turn inhibits activated coagulation factors, specifically Factor Xa and, to a lesser extent, thrombin (Factor IIa). This inhibition prevents the conversion of fibrinogen to fibrin, thereby reducing clot formation. In the context of clinical research conducted by the Henan University of Traditional Chinese Medicine (specifically trial NCT03591471), low molecular weight heparin calcium was utilized as a component of the standard western medicine control regimen for children with Henoch-Schönlein purpura nephritis (HSPN). It is used in this indication to manage the hypercoagulable state and microthrombosis associated with glomerular inflammation.

Other names
LMWH-Calow molecular weight heparin calcium injection
02

Targets

F10 (Factor Xa)

Beyond the preview

Go deeper on low molecular weight heparin calcium (Henan University of Chinese Medicine).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on low molecular weight heparin calcium (Henan University of Chinese Medicine).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call